PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11113363-6	2000	zDEVD-fmk, an irreversible inhibitor of caspase-3-like enzymes, and cytochalasin D, an actin depolymerizing agent, blocked caspase-3 cleavage and delayed cell death.	Cytochalasin D	68-82	caspase 3	Homo sapiens	123-132	
26320605-10	2015	Epithelial cells treatment with cytochalasin D caused the inhibition of B182 internalisation and caspase 3 activation.	Cytochalasin D	32-46	caspase 3	Homo sapiens	97-106	
20010439-0	2010	Cytochalasin D, LY294002 and olomoucine synergize in promoting death of melanoma cells through activation of caspase-3 and apoptosis.	Cytochalasin D	0-14	caspase 3	Homo sapiens	109-118	
20010439-4	2010	We tested cell viability, terminal dUTP nick-end labeling and activation of caspase-3 upon exposure to cytochalasin D, LY294002 and olomoucine, added either alone or in various combinations.	Cytochalasin D	103-117	caspase 3	Homo sapiens	76-85	
20010439-8	2010	In particular, the triple combination of cytochalasin D+LY294002+olomoucine was almost as effective as staurosporine in inducing caspase-3 activity and apoptosis.	Cytochalasin D	41-55	caspase 3	Homo sapiens	129-138	
12907684-5	2003	CD also suppressed activation of downstream signaling of p38 kinase and PKC, such as NF-kappaB activation, p53 accumulation, and caspase-3 activation, which are necessary for NO-induced apoptosis.	Cytochalasin D	0-2	caspase 3	Homo sapiens	129-138